X-Vax Technology Revenue and Competitors
Estimated Revenue & Valuation
- X-Vax Technology's estimated annual revenue is currently $1.4M per year.
- X-Vax Technology's estimated revenue per employee is $155,000
Employee Data
- X-Vax Technology has 9 Employees.
- X-Vax Technology grew their employee count by -40% last year.
X-Vax Technology's People
Name | Title | Email/Phone |
---|---|---|
1 | Head Technical Operations & Portfolio Management | Reveal Email/Phone |
2 | CHIEF OPERATING OFFICER | Reveal Email/Phone |
3 | Project Manager | Reveal Email/Phone |
4 | Project Manager | Reveal Email/Phone |
5 | President & CEO | Reveal Email/Phone |
X-Vax Technology Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $15.3M | 99 | 5% | N/A | N/A |
#2 | $1.1M | 7 | -30% | N/A | N/A |
#3 | $3.7M | 24 | 4% | N/A | N/A |
#4 | $4.3M | 28 | -3% | N/A | N/A |
#5 | $2.5M | 16 | N/A | N/A | N/A |
#6 | $0.8M | 5 | 0% | N/A | N/A |
#7 | $1.1M | 7 | 0% | N/A | N/A |
#8 | $2.5M | 16 | 7% | N/A | N/A |
#9 | $1.4M | 9 | -25% | N/A | N/A |
#10 | $0.6M | 4 | 0% | N/A | N/A |
What Is X-Vax Technology?
We're a biotech company committed to developing vaccines against pathogens acquired by mucosal infection such as herpes. Our research leads us to believe that the new approach we're taking could succeed in defeating herpes by inducing antibodies that mediate the killing of infected cells. We're strongly committed to this fight, and so far our work has been supported with unprecedented data in multiple preclinical models.
keywords:N/AN/A
Total Funding
9
Number of Employees
$1.4M
Revenue (est)
-40%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0.7M | 9 | 0% | N/A |
#2 | $0.9M | 10 | -9% | N/A |
#3 | $0.8M | 11 | N/A | N/A |
#4 | $1M | 11 | 0% | N/A |
#5 | $1M | 11 | 83% | N/A |